Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.0B | 2.6B | 3.1B | 2.7B |
| Cost of revenue | 2.4B | 2.2B | 2.5B | 2.2B |
| Gross profit | 572M | 356M | 550M | 441M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 138M | 156M | 139M | 133M |
| Other operating expenses | 29M | 32M | 32M | 29M |
| Operating income | 405M | 168M | 379M | 279M |
| Non operating interest income | ||||
| Income | 26M | 29M | 31M | 31M |
| Expense | — | — | — | — |
| Other income expense | -3M | -27M | 26M | -5M |
| Pretax income | 428M | 170M | 436M | 305M |
| Tax provision | 119M | 47M | 119M | 77M |
| Net income | 313M | 126M | 319M | 228M |
| Basic EPS | 0.8 | 0.3 | 0.8 | 0.6 |
| Diluted EPS | 0.8 | 0.3 | 0.8 | 0.6 |
| Basic average shares | 376M | 379M | 384M | 389M |
| Diluted average shares | 378M | 382M | 385M | 391M |
| EBITDA | 517M | 316M | 473M | 402M |
| Net income from continuing op. | 313M | 126M | 319M | 228M |
| Minority interests | -21M | -11M | -22M | -16M |
| Preferred stock dividends | — | — | — | — |